Clinical Trial Update: Hydroxyurea in Primary Progressive Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating hydroxyurea for primary progressive multiple sclerosis was terminated (status: TERMINATED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: S. Andrea Hospital | Conditions: Multiple Sclerosis | Phase 2, Phase 3 | Status: TERMINATED